论文部分内容阅读
目的评价艾司洛尔治疗阵发性室上性心动过速的疗效和安全性。方法应用艾司洛尔治疗阵发性室上性心动过速84例,观察其转复窦性心律和控制心室率的情况,并记录用药前后的血压变化。结果静脉注射艾司洛尔起效时间为(4.1±1.2)m in,治疗有效率为78.6%;副作用较少,静脉注射后仅轻度影响收缩压,共有6例出现低血压,给予快速补液后好转,3例出现心动过缓,给予阿托品后好转。结论艾司洛尔能有效地转复阵发性室上性心动过速,且使用安全。
Objective To evaluate the efficacy and safety of esmolol in the treatment of paroxysmal supraventricular tachycardia. Methods Esmolol was used in the treatment of 84 cases of paroxysmal supraventricular tachycardia. The changes of sinus rhythm and ventricular rate were observed and the changes of blood pressure before and after treatment were recorded. Results The onset time of esmolol intravenous injection was (4.1 ± 1.2) min, the effective rate was 78.6%. There were fewer side effects and systolic blood pressure was only slightly affected after intravenous injection. A total of 6 patients experienced hypotension and received rapid rehydration After the improvement, 3 cases of bradycardia, giving atropine improved. Conclusion Esmolol can effectively recover paroxysmal supraventricular tachycardia and is safe to use.